IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0195359
(2011-08-01)
|
등록번호 |
US-8202545
(2012-06-19)
|
발명자
/ 주소 |
- Bui, Can V.
- Bui, legal representative, Cuong Q.
|
출원인 / 주소 |
|
대리인 / 주소 |
Wilson Sonsini Goodrich & Rosati
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
2 |
초록
▼
A composition comprising vegetable/herbal based dietary ingredients, or extracts, which contains vitamins and nutrients that provide a novel nontoxic treatment for liver cancers, hepatitis, and liver cirrhosis. The composition can be taken as a daily dietary supplement to enhance normal physiologica
A composition comprising vegetable/herbal based dietary ingredients, or extracts, which contains vitamins and nutrients that provide a novel nontoxic treatment for liver cancers, hepatitis, and liver cirrhosis. The composition can be taken as a daily dietary supplement to enhance normal physiological functions of the body. The said composition, or extracts thereof, are useful and effective in the treatment and prevention of liver and possibly other cancers. The compositions are also useful for administration to patients with pre-existing hepatitis and/or liver cirrhosis. The compositions or extracts thereof may be useful for treating other cancers and other disorders, diseases, or conditions.
대표청구항
▼
1. A method of treating an individual with liver cancer, said method comprising administering to the individual an effective amount of a composition comprising: between about 20 to about 26% Brassica oleracea; between about 30 to about 36% Daucus carota; between about 22 to about 28% Apium L.;betwee
1. A method of treating an individual with liver cancer, said method comprising administering to the individual an effective amount of a composition comprising: between about 20 to about 26% Brassica oleracea; between about 30 to about 36% Daucus carota; between about 22 to about 28% Apium L.;between about 0.1 to about 1.5% Petroselinum crispum; between about 9 to about 15% Spinacia oleracea L;between about 6 to about 12% Beta vulgaris; between about 0.1 to about 1.5% aloe vera; andbetween about 0.1 to 1.5% honey. 2. The method of claim 1, wherein said cancer is hepatocellular carcinoma. 3. The method of claim 1, wherein said cancer is hepatobiliary carcinoma. 4. The method of claim 1, wherein said composition is administered orally or by means of an injection. 5. The method of claim 4, wherein the composition is in the orally administrable form, and the orally administrable form is selected from the group consisting of a juice, a tablet, a powder, a suspension, an emulsion, a capsule, a granule, a troche, a pill, a liquid, a spirit, a syrup, and a limonade. 6. The method of claim 4, wherein the composition is in the injectable form and the injectable form is selected from the group consisting of a liquid, a suspension, and a solution. 7. A method of treating an individual with liver damage caused by chemoembolization, said method comprising administering to the individual a composition comprising: between about 20 to about 26% Brassica oleracea; between about 30 to about 36% Daucus carota; between about 22 to about 28% Apium L.;between about 0.1 to about 1.5% Petroselinum crispum; between about 9 to about 15% Spinacia oleracea L;between about 6 to about 12% Beta vulgaris; between about 0.1 to about 1.5% aloe vera; andbetween about 0.1 to 1.5% honey, wherein said composition is administered in an amount sufficient to aide in liver regeneration for normal liver parenchyma damaged in hepatic chemoembolization. 8. The method for the treatment of liver damage as described in claim 7 wherein said composition is administered orally or by means of an injection. 9. A method for the treatment of an individual suffering from cirrhosis of the liver, said method comprising administering to the individual a composition comprising: between about 20 to about 26% Brassica oleracea; between about 30 to about 36% Daucus carota; between about 22 to about 28% Apium L.;between about 0.1 to about 1.5% Petroselinum crispum; between about 9 to about 15% Spinacia oleracea L;between about 6 to about 12% Beta vulgaris; between about 0.1 to about 1.5% aloe vera; andbetween about 0.1 to 1.5% honey. 10. A method for the treatment of an individual suffering from hepatitis of the liver, said method comprising administering to the individual a composition comprising: between about 20 to about 26% Brassica oleracea; between about 30 to about 36% Daucus carota; between about 22 to about 28% Apium L.;between about 0.1 to about 1.5% Petroselinum crispum; between about 9 to about 15% Spinacia oleracea L;between about 6 to about 12% Beta vulgaris; between about 0.1 to about 1.5% aloe vera; andbetween about 0.1 to 1.5% honey. 11. A method of treating an individual with liver cancer, said method comprising administering to the individual a composition comprising: a Brassica oleracea component, said Brassica oleracea component comprises about 1031.48 mg potassium;a Apium graveolens component, said Apium graveolens component comprises about 979.8 mg potassium;a Spinacia oleracea component, said Spinacia oleracea component comprises about 885.1 mg potassium;a Daucus carota component, said Daucus carota component comprises about 1043 mg potassium;a Beta vulgaris component, said Beta vulgaris component comprises about 347.06 mg potassium;a Petroselinum crispum component, said Petroselinum crispum component comprises about 89.46 mg potassium; anda honey component, said honey component comprises about 11 mg potassium. 12. The method of claim 11, wherein said cancer is at least one of hepatocellular carcinoma and hepatobiliary carcinoma. 13. The method of claim 11, wherein said composition is administered orally or by means of an injection. 14. The method of claim 13, wherein the composition is in the orally administrable form, and the orally administrable form is selected from the group consisting of a juice, a tablet, a powder, a suspension, an emulsion, a capsule, a granule, a troche, a pill, a liquid, a spirit, a syrup, and a limonade. 15. The method of claim 13, wherein the composition is in the injectable form and the injectable form is selected from the group consisting of a liquid, a suspension, and a solution. 16. A method of treating an individual with liver cancer, said method comprising administering to the individual a composition comprising: a Brassica oleracea component, said Brassica oleracea component comprises about 144.6 mg calcium;a Apium graveolens component, said Apium graveolens component comprises about 136.3 mg calcium;a Spinacia oleracea component, said Spinacia oleracea component comprises about 159.0 mg calcium;a Daucus carota component, said Daucus carota component comprises about 119.2 mg calcium;a Beta vulgaris component, said Beta vulgaris component comprises about 18.76 mg calcium;a Petroselinum crispum component, said Petroselinum crispum component comprises about 21.3 mg calcium; anda honey component, said honey component comprises about 1 mg calcium. 17. The method of claim 16, wherein said cancer is at least one of hepatocellular carcinoma and hepatobiliary carcinoma. 18. The method of claim 16, wherein said composition is administered orally or by means of an injection. 19. The method of claim 18, wherein the composition is in the orally administrable form, and the orally administrable form is selected from the group consisting of a juice, a tablet, a powder, a suspension, an emulsion, a capsule, a granule, a troche, a pill, a liquid, a spirit, a syrup, and a limonade. 20. The method of claim 18, wherein the composition is in the injectable form and the injectable form is selected from the group consisting of a liquid, a suspension, and a solution.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.